AstraZeneca PLC (AZN) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Astrazeneca Plc.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.723 -- 00:00:04.047 Good morning to those joining from the UK and the US. 00:00:04.047 -- 00:00:08.412 Good afternoon to those in Central Europe and good evening to those listening in Asia. 00:00:08.412 -- 00:00:12.056 Welcome to AstraZeneca's Q1 2026 webinar 00:00:12.056 -- 00:00:14.839 for investors and analysts. 00:00:14.839 -- 00:00:19.922 Before I hand over to AstraZeneca, I'd like to read the Safe Harbor Statement. 00:00:19.945 -- 00:00:24.049 The company intends to utilize the safe harbor provisions of the United States Private 00:00:24.049 -- 00:00:28.292 Securities Litigation Reform Act of 1995. 00:00:28.297 -- 00:00:32.903 Participants on this call may make forward-looking statements with respect to the operations 00:00:32.903 -- 00:00:36.207 and financial performance of AstraZeneca. 00:00:36.207 -- 00:00:40.532 Although we believe our expectations are based on reasonable assumptions, by their very 00:00:40.532 -- 00:00:45.659 nature, forward-looking statements involve risks and uncertainties, and may be influenced 00:00:45.659 -- 00:00:50.585 by factors that could cause actual results to differ materially from those expressed 00:00:50.585 -- 00:00:54.098 or implied by these forward-looking statements. 00:00:54.098 -- 00:00:58.003 Any forward-looking statements made on this call reflect the knowledge and information 00:00:58.003 -- 00:01:01.247 available at the time of this call. 00:01:01.247 -- 00:01:05.812 The company undertakes no obligation to update forward-looking statements. 00:01:05.812 -- 00:01:09.617 Please carefully review the forward-looking statements disclaimer in the slide deck that 00:01:09.617 -- 00:01:12.741 accompanies this presentation and webcast. 00:01:12.741 -- 00:01:16.686 There will be an opportunity to ask questions...